TY  - JOUR
AU  - Gulde, Sebastian
AU  - Wiedemann, Tobias
AU  - Schillmaier, Mathias
AU  - Valença, Isabel
AU  - Lupp, Amelie
AU  - Steiger, Katja
AU  - Yen, Hsi-Yu
AU  - Bäuerle, Stephen
AU  - Notni, Johannes
AU  - Luque, Raul
AU  - Schmid, Herbert
AU  - Schulz, Stefan
AU  - Ankerst, Donna P
AU  - Schilling, Franz
AU  - Pellegata, Natalia S
PY  - 2021
DO  - 10.3390/cancers13123097
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/18106
T2  - Cancers
AB  - Invasive nonfunctioning pituitary tumors (NFPTs) are non-resectable neoplasms associated with frequent relapse and significant comorbidities. Current treatments, including somatostatin receptor 2 (SSTR2)-directed somatostatin analogs (SSAs), often...
LA  - en
PB  - MDPI
KW  - MRI
KW  - Nonfunctioning pituitary tumors
KW  - Octreotide
KW  - Pasireotide
KW  - Sex differences in drug response
KW  - Somatostatin receptors
KW  - Rats
KW  - Octreotide
KW  - Somatostatin receptor 2
KW  - Pituitary Neoplasms
KW  - Somatostatin
KW  - Magnetic Resonance Imaging
KW  - Cell Proliferation
TI  - Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors.
TY  - research article
VL  - 13
ER  -